Kestra Medical Technologies, Ltd.
KMTS
$26.07
-$0.33-1.25%
NASDAQ
| 07/31/2025 | 04/30/2025 | 07/31/2024 | |||
|---|---|---|---|---|---|
| Net Income | 50.39% | -142.01% | 10.77% | ||
| Total Depreciation and Amortization | 10.46% | -2.75% | -32.18% | ||
| Total Amortization of Deferred Charges | 27.10% | 117.06% | 0.00% | ||
| Total Other Non-Cash Items | -89.75% | 3,036.55% | -12.46% | ||
| Change in Net Operating Assets | -72.86% | -2,913.01% | -165.35% | ||
| Cash from Operations | -10.87% | -28.91% | -17.07% | ||
| Capital Expenditure | -2.80% | -97.98% | -67.98% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -86.93% | -- | -45.24% | ||
| Cash from Investing | -6.07% | -91.02% | -69.13% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | 727.20% | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 45.81% | -2,807.56% | 4,968.56% | ||
| Cash from Financing | -100.87% | 180,522.69% | 850.09% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -119.85% | 912.03% | 1,434.89% | ||